Sleep Aids Flashcards

0
Q

What class of drugs are used to treat insomnia in the short-term?

A

Sleep aids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

What is the name for the subjective complaint of difficulty falling asleep, staying asleep, and/or experiencing restorative sleep that results in daytime impairment?

A

Insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the four main classes of FDA-approved medications for the treatment of insomnia?

A

Benzodiazepine receptor agonists

Non-benzodiazepine receptor agonist

Tricyclic antidepressant

Melatonin receptor agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What about the use of over-the-counter products such as antihistamines, Valerian, and melatonin and off label use of antidepressants, antipsychotics, and anticonvulsant drugs for the treatment of insomnia?

A

There is limited data to support the use of these medications in insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the mechanism of action for benzodiazepine receptor agonists?

A

They nonselectively bind to the alpha subunits on the gamma-aminobutyric acid type A (GABA–A) receptor complex

This results in the enhancement of GABAs inhibitory effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Similar to benzodiazepine receptor agonists, what is the mechanism of action for non-benzodiazepine receptor agonists?

A

They also bind to the GABA–A receptor, but have a higher selectivity for alpha receptor subunits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of action for zolpidem and zaleplon?

A

They also bind to the GABA–A receptor, but have a greater affinity for the alpha-1 subtype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the mechanism of action for eszipclone?

A

They also bind to the GABA–A receptor, but has a greater affinity for the alpha-2 and 3 subtypes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What advantage does the selectivity demonstrated by these medications result in?

A

They end up being more sedation-specific, with fewer adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Melatonin is an endogenous hormone released from which gland? What is it released in response to? From what nucleus?

A

The pineal gland

In response to light and dark signals

From the suprachiasmatic nucleus (SCN)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the three melatonin receptors in the body?

A

MT1, MT2, and MT3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Which two melatonin receptors regulate the wake-sleep cycle?

A

MT1 and MT2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of action (receptor binding) for the medication Ramelteon? What endogenous hormone does it mimic?

A

It is a melatonin receptor agonist that binds to MT1 and MT2 receptors and;

Mimics melatonin’s sleep-promoting properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

At low doses, which tricyclic antidepressant is a selective histamine-1 antagonist that produces sedating effects?

A

Doxepin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What happens to doxepin, with regard to sedating effects, at higher doses? Which 3 effects does it show at higher doses?

A

It loses its sedating effects at higher doses

At higher doses it becomes anti-cholinergic, anti-serotonergic, and anti-adrenergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When appropriate, what should be utilized as an initial Non-pharmacologic intervention, and is considered effective, for the management of insomnia?

A

Psychological and behavioral therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Under what 3 conditions is pharmacologic intervention indicated for insomnia?

A

When a patient prefers the use of a medication

When immediate symptom relief is required

When the sleep disturbance produces significant distress or impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Whenever possible, what should the therapeutic approach to insomnia be?

A

Medications should be utilized short-term in combination with non-pharmacologic strategies whenever possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The number 3 most common adverse effects of benzodiazepine receptor agonists are?

A

Drowsiness, dizziness, and headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What common adverse effect is associated with benzodiazepines with long durations of action?

A

Residual daytime sedation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

If a benzodiazepine with a long duration of action is causing residual daytime sedation, what should be done?

A

Switch to a medication with an intermediate or short duration of action; this will decrease daytime drowsiness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Which adverse effect of benzodiazepine receptor agonists is considered to be dose-dependent?

What should be done if a patient complains of this specific adverse effect?

A

Anterograde amnesia

The dose should be lowered and the patient instructed to take the medication only at bedtime

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Benzodiazepines with short durations of action tend to cause what specific type of adverse effect?

A

Rebound insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is rebound insomnia?

A

This refers to a rapid return of difficulty with sleep initiation and/or maintenance

It may be worse than before treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How do you prevent rebound insomnia?

A

Gradually taper the benzodiazepine by 10% or less at 5-to-7 day intervals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Can benzodiazepine receptor agonists cause withdrawal symptoms on discontinuation?

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Why are the adverse effects associated with benzodiazepines a concern in the elderly?

A

Because they may metabolize these medications more slowly and are at higher risk for falls

27
Q

What are the 4 most common adverse effects of non-benzodiazepine receptor agonists?

A

Headache, drowsiness, fatigue, and dizziness

28
Q

Eszopiclone, a non-benzodiazepine receptor agonist, can cause what adverse effect at higher doses?

A

Metallic aftertaste

29
Q

What are two generic benzodiazepine receptor agonists?

A

Estazolam

Flurazepam

30
Q

Benzodiazepine receptor agonist

Dural

A

Quazepam

31
Q

Benzodiazepine receptor agonist

Restoril

A

Temazopam

32
Q

Benzodiazepine receptor agonist

Halcion

A

Triazolam

33
Q

What 3 indications are estazolam, flurazepam, and quazepam (Dural) used for?

A

Difficulty falling asleep

Frequent nocturnal awakening

Early-morning awakening

34
Q

Benzodiazepine receptor agonists, Temazepam (Restoril) and Triazolam (Halcion) are used for what FDA approved indication?

A

Difficulty falling asleep

35
Q

Non-benzodiazepine receptor agonist

Ambien

A

Zolpidem

36
Q

Non-benzodiazepine receptor agonist

Ambien CR

A

Zolpidem CR

37
Q

Non-benzodiazepine receptor agonist

Edluar

A

Zolpidem sublingual

38
Q

Non-benzodiazepine receptor agonist

Intermezzo

A

Zolpidem sublingual

39
Q

Non-benzodiazepine receptor agonist

Zolpimist

A

Zolpidem oral spray

40
Q

Non-benzodiazepine receptor agonist

Lunesta

A

Eszopiclone

41
Q

Non-benzodiazepine receptor agonist

Sonata

A

Zaleplon

42
Q

Zolpidem (Ambien), zolpidem sublingual (Edluar), Zolpidem oral spray (Zolpimist), and Zaleplon (Sonata) are all used for what single indication?

A

Difficulty falling asleep

43
Q

Which 2 non-benzodiazepine receptor agonists are used for both difficulty with sleep onset and/or sleep maintenance?

A

Zolpidem CR (Ambien CR)

Eszopiclone (Lunesta)

44
Q

When should the non-benzodiazepine receptor agonist zolpidem sublingual (intermezzo) be used?

A

It should be used for middle-of-the-night waking followed by difficulty returning to sleep

It is not indicated if the patient has less than four hours of bedtime remaining before the planned waking time

45
Q

Tricyclic antidepressant

Silenor

A

Doxepin

46
Q

Which tricyclic antidepressant is used for difficulty with sleep maintenance?

A

Doxepin (Silenor)

47
Q

Melatonin (MT1 and MT2) receptor agonist

Rozerem

A

Ramelteon

48
Q

At higher doses, what can the non-benzodiazepine receptor agonist Zaleplon cause?

A

Rebound insomnia

49
Q

What unique adverse effect has zolpidem been associated with?

A

Parasomnias, including sleepwalking and sleep-eating

50
Q

It is recommended by the manufacturers of zolpidem (Ambien) that women begin treatment with lower starting doses. What is this based on?

A

This is based on data regarding the relationship between psychomotor performance and drug blood levels

51
Q

What are the most common adverse effects reported in clinical trials for doxepin?

A

Somnolent/sedation

nausea

increased upper respiratory tract infections

52
Q

At higher doses, what are the adverse effects associated with doxepin (3)?

A

Orthostatic hypotension

anti-cholinergic effects

cardiac conduction delay

53
Q

Is there any abuse potential associated with doxepin? Are there any withdrawal symptoms on discontinuation?

A

No; No

54
Q

True or false: Ramelteon is generally well tolerated

A

True

55
Q

What are the most common adverse effects reported in clinical trials for Ramelteon?

A

Headache

somnolence

dizziness

nausea

56
Q

Should a patient be concerned about abuse potential or withdrawal symptoms upon discontinuation with the use of Ramelteon?

A

No

57
Q

What drug-to-drug interaction is exhibited when CNS depressants (e.g. opioids) are combined with the use of benzodiazepine receptor agonists, non-benzodiazepine receptor agonists, doxepin, and Ramelteon?

A

There is a potentiation of impaired cognitive and motor effects

Therefore, it is recommended that sleep aid be initiated at a low dose and titrated based on the patient’s response

58
Q

What drug-to-drug interaction is exhibited when alcohol is combined with the use of benzodiazepine receptor agonists, non-benzodiazepine receptor agonists, doxepin, and Ramelteon?

A

There is a potentiation of impaired cognitive and motor effects

Therefore, patients should be educated to avoid alcohol while taking these medications

59
Q

What is the drug-to-drug interaction of food with zolpidem, doxepin, eszopiclone, zaleplon?

A

If taken with or immediately after a meal, can delay onset of sleep

Therefore, patients should take these medications on an empty stomach

60
Q

What happens when you use a strong CYP3A4 inhibitors (such as azole antifungals and HIV protease inhibitors) with medication such as zolpidem, triazolam, estazolam, eszopiclone and Ramelteon?

A

Increased plasma concentration of the sleep aid

Therefore, avoid using these medications with triazolam or estazolam

In the case of zolpidem, eszopiclone, or ramelteon, initiate treatment at a low dose and monitor for side effects

61
Q

How does the use of fluvoxamine influence the simultaneous use of ramelteon?

A

It increases the plasma concentration of the sleep aid

Therefore, avoid the use of ramelteon

62
Q

Which medications can be used to treat not only their respective primary disorders, but also insomnia?

A

Trazodone, mirtazapine, and neuroleptics

63
Q

In certain cases, can treating the patient’s psychiatric illness improve insomnia?

A

Yes, for example, a common symptom of depression is insomnia, and, as the patient’s depression improves, sleep often improves.

64
Q

Why should one use caution when treating a patient with benzodiazepines and non-benzodiazepine receptor agonists?

A

Patients can become tolerant and require higher doses

Therefore, monitor for withdrawal symptoms after discontinuing the medication

65
Q

What have studies shown regarding melatonin?

A

Studies have shown that melatonin does not help with insomnia, but is useful for resetting the sleep cycle after sleep disruptions such as shiftwork or jetlag

Liira J et al.: pharmacological interventions for sleepiness and sleep disturbances caused by shift work. Cochran database syst. Rev. 8:, 2014.